EMA seeks executive director

Andreas Pott will be acting executive director until position is filled

The European Medicines Agency (EMA) is seeking a new executive director. Its current head, Thomas Lönngren, is leaving the post on 31 December, following the end of his second five-year mandate.

While EMA searches for a permanent replacement, its current head of administration, Andreas Pott, will serve as acting executive director.

University of Hamburg graduate, Pott has been the agency’s administration chief since 2000, having previously worked for the European Parliament and the EU’s translation service.

Swede Lönngren is a former deputy director-general of the Swedish Medical Products Agency (MPA).

You may also like

Packaging

SmartSkin unveils pharma seal assurance solution with real-time insights

The breakthrough solution will give manufacturers real-time visibility into container closure integrity and capping performance, with SmartSkin aiming to debut the technology at the upcoming IPSE 4.0 in Barcelona
Regulatory

AstraZeneca's New Drug Application for hypertension drug accepted under FDA Priority Review

Baxdrostat has had positive Phase III trial results and, if approved, could be the first aldosterone synthase inhibitor to receive regulatory authorisation
Manufacturing

IDA Ireland releases whitepaper on the future of biopharma manufacturing in Ireland

The report highlights details on Ireland's geopolitical stability, its high regulatory standards and how the country is forging ahead as a leader in the advanced therapy and next-gen biologics sector
Pharma 5.0

Excelsior Sciences raises $95m for AI-powered small molecule discovery and manufacturing

Deerfield Management, Khosla Ventures and Sofinnova Partners co-lead Series A fundraising for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring
Manufacturing

Thermo Fisher Scientific doubles down on investment in Asia

New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
Sustainability

Free online course introduces fundamentals of SFC

Learn how SFC can improve efficiency and reduce environmental impact
Contamination Control

Eurofins launches first GMP-compliant PFAS screening solution for the medical device industry

Eurofins Medical Device Services North America has introduced the industry’s first GMP PFAS testing and screening platform, helping manufacturers meet tightening global regulations and safeguard device and patient safety
Subscribe now